Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (OTCBB - OTCQB:SNGX)

1.51
Delayed Data
As of 3:04pm ET
 -0.12 / -7.36%
Today’s Change
0.91
Today|||52-Week Range
2.95
+54.16%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close1.63
Today’s open1.56
Day’s range1.40 - 1.63
Volume394,818
Average volume (3 months)191,637
Market cap$41.9M
Dividend yield--
Data as of 3:04pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)+33.85%
Earnings growth (this year)-51.16%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+118.45%
P/E ratioNM
Price/Sales3.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
STEMStemCells Inc+0.01+1.39%
ROSGRosetta Genomics Ltd-0.08-2.60%
BPMXBioPharmX Corp-0.03-1.37%
OXGNOXiGENE Inc-0.05-3.62%
Data as of 3:20pm ET, 08/03/2015

Financials

Next reporting dateAugust 14, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$7.0M
Annual profit (last year)-$6.7M
Net profit margin-95.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer, Secretary &
VP
Joseph Michael Warusz
Corporate headquarters
Princeton, New Jersey

Forecasts